Novo
-
USA
Novo Nordisk’s Martin Holst Lange previews obesity pill
A version of this article was first published in the CNBC’s healthy return bulletin, which brought the latest health news…
Read More » -
USA
Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes
A combination image shows Zepbound’s injection item, Eli Lilly’s weight loss medication and Wegovy boxes made by Novo Nordisk. Hollie…
Read More » -
USA
Denmark slashes 2025 growth forecast amid Novo Nordisk slowdown
On February 5, 2025, Bagsvaerd presented an annual report in Novo Nordisk in Denmark, while box -office records breaking diabetes…
Read More » -
USA
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo is sitting outside the center of Eli Lilly in Indiana, Indiana, Indiana on 17…
Read More » -
Australia
Ozempic maker Novo Nordisk cuts price of wonder drug in half
Loading Unlike weight loss drugs, Özempic is covered with insurance plans for diabetes treatment. Patients rarely pay full price. However,…
Read More » -
Australia
Ozempic maker Novo Nordisk cuts price of wonder drug in half
Loading Unlike weight loss drugs, Özempic is covered with insurance plans for diabetes treatment. Patients rarely pay full price. However,…
Read More » -
USA
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of novo Nordisk on March 8, 2024 at a pharmacy in London. Hollie Adams | Reuters Novo Nordisk…
Read More » -
USA
Novo Nordisk shares pop 5% after Wegovy receives U.S. approval for liver disease
On Monday, April 28, 2025, Vermont, Waterbury, wegovy injection items held in Vermont. Shelby Knowles | Bloomberg | Getty Images…
Read More » -
Australia
Novo Nordisk warns of layoffs as pressure mounts
7 August 2025 03:30 | News Novo Nordisk is waiting for the ongoing competition from the imitating versions of Wegovy…
Read More » -
UK
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry
The sales of injectable diabetes drugs, including Novo Nordisk’s Ozempic, slowed down sharply in the midst of the threat of…
Read More »
